Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 11 Projects
Project # Contact PI Funding Organization Fiscal Year
Open-label Clinical Trial of Nabilone for Neuropsychiatric Symptoms in Frontotemporal Dementia
ADDF-34 Ducharme, Simon Alzheimer's Drug Discovery Foundation 2021
Does intranasal insulin administration preserve cognitive function after cardiac surgery?
GC-201711-2014025 Sato, Hiroaki Alzheimer's Drug Discovery Foundation 2019
Nabilone for Agitation Blinded Intervention Trial (NAB-IT)
GC-201808-2016354 Lanctôt, Krista Alzheimer's Drug Discovery Foundation 2018
Reshaping Mitochondrial Efficiency and Integrity to Treat Parkinson’s Disease
EUJPND-BC|Krembil-Slack-349 Slack, Ruth Brain Canada|Krembil Foundation 2016
Safety & Efficacy of nabilone in institutionalized patients with Alzheimer's Disease: a pilot study
20140503-LANCTOT-2014 LANCTOT, KRISTA L. Alzheimer's Drug Discovery Foundation 2014
ADD ON: Sartans to Slow Alzheimer's Disease: A Randomized, Open-Label, Head-to-Head, Proof-of-Concept Study of Angiotensin Receptor Blockers Versus ACE Inhibitors in Hypertensive Mild-Moderate AD Patients using Ventricular Enlargement as Primary Outcome
20141208-BLACK-2014 Black, Sandra Alzheimer's Drug Discovery Foundation 2014
Sartans to Slow Alzheimer's Disease: A Randomized, Open-Label, Head-to-Head, Proof-of-Concept Study of Angiotensin Receptor Blockers Versus ACE Inhibitors in Hypertensive Mild-Moderate AD Patients using Ventricular Enlargement as Primary Outcome
20121211-BLACK-2013 Black, Sandra Alzheimer's Drug Discovery Foundation 2013
Novel modulators of apoE function
290102.01-WELLINGTON-2012 WELLINGTON, CHERYL LEA Alzheimer's Drug Discovery Foundation 2012
The therapeutic potential of ABCA1 and apoE for Alzheimer's Disease
290102-WELLINGTON-2009 WELLINGTON, CHERYL LEA Alzheimer's Drug Discovery Foundation 2009
Suppression of glial HO-1 activity as a potential neurotherapeutic intervention in Alzheimer's disease
280302-Gupta-2008 GUPTA, AJAY Alzheimer's Drug Discovery Foundation 2008